First-Seizure Clinic Attendance Cuts Later Health Care Utilization
By Elana Gotkine HealthDay Reporter
FRIDAY, May 24, 2024 -- First-seizure clinic (FSC) attendance is associated with reduced rates of subsequent health care utilization, according to a study published online May 23 in JAMA Neurology to coincide with the annual scientific meeting of the Australian and New Zealand Association of Neurologists, held from May 21 to 24 in Adelaide, Australia.
Yingtong Li, M.D., from Monash University in Melbourne, Australia, and colleagues conducted a retrospective cohort study involving patients who booked appointments at two FSCs between 2007 and 2018 to examine whether FSC attendance and time to FSC are associated with subsequent health care utilization and mortality. Of the 10,162 patients with appointments at FSCs, 9,392 were linked for analysis, with a mean follow-up of 6.9 years.
The researchers found that FSC attendance was associated with reduced subsequent all-cause emergency presentations and all-cause hospitalization (adjusted incidence rate ratios [aIRRs], 0.72 and 0.81, respectively). Compared with those who attended a rescheduled, delayed appointment, those who attended the first scheduled appointment had reduced subsequent all-cause emergency presentations, all-cause hospitalization, and seizure-related presentations (aIRRs, 0.83, 0.71, and 0.40, respectively), as well as lower mortality (hazard ratio, 0.82). Male sex, injury at emergency presentation, psychiatric comorbidity, previous seizure-related presentations, and delays (>14 days) between FSC referral and appointment were associated with nonattendance (adjusted relative risks, 1.12, 1.12, 1.68, 1.35, and 1.35, respectively).
"Our findings provide an evidence base to adequately resource FSCs to expand access and reduce wait times to less than 14 days," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
Angiotensin Receptor Blocker Use Linked to Lower Incidence of Epilepsy
FRIDAY, June 21, 2024 -- For patients with hypertension, angiotensin receptor blockers (ARBs) are associated with a reduced incidence of epilepsy compared with other...
Epilepsy Surgery for Neuroglial Tumors Shows Good Long-Term Outcomes
MONDAY, June 17, 2024 -- Patients with neuroglial tumors are ideal epilepsy surgical candidates, with good long-term outcomes observed, according to a study published online May...
In Utero Exposure to Antiseizure Meds Does Not Affect Child Creativity
WEDNESDAY, May 29, 2024 -- There are no differences in creative thinking at age 4.5 years for children of women with epilepsy (WWE) and children of healthy women (HW), but fetal...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.